New hope for dry AMD: drug aims to slow geographic atrophy
Disease control
Completed
This study tested an experimental drug called ALK-001 in people with geographic atrophy, an advanced form of dry age-related macular degeneration that causes blind spots. About 200 participants received the drug and 100 received a placebo. The goal was to see if ALK-001 could slo…
Phase: PHASE2, PHASE3 • Sponsor: Alkeus Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 10:41 UTC